Literature DB >> 23020778

DNA repair and replication proteins as prognostic markers in melanoma.

Liang Song1, Tammy Robson, Tamasin Doig, Thomas Brenn, Marie Mathers, Ewan R Brown, Val Doherty, John M S Bartlett, Niall Anderson, David W Melton.   

Abstract

AIMS: Elevated expression of DNA repair and replication genes has been reported in thick, non-fixed primary melanomas that subsequently went on to metastasize, when compared to non-recurrent primary tumours. This increased expression could contribute to the extreme resistance shown by melanoma to DNA-damaging chemotherapeutics. We have investigated the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in melanoma. METHODS AND
RESULTS: We used a tissue microarray containing samples from all stages of melanomagenesis to investigate the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in a larger, more representative and readily available set of fixed primary melanomas. High expression of topoisomerase IIα (TOP2A), that relieves torsional stress during DNA replication, and XRCC5 (Ku80), required for DNA double-strand break repair, were associated with significantly worse survival.
CONCLUSIONS: Two (XRCC5 and TOP2A) of seven DNA repair and replication proteins studied were prognostic for melanoma.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020778     DOI: 10.1111/j.1365-2559.2012.04362.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

Review 1.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

2.  Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.

Authors:  Nail Fatkhutdinov; Katrin Sproesser; Clemens Krepler; Qin Liu; Patricia A Brafford; Meenhard Herlyn; Katherine M Aird; Rugang Zhang
Journal:  Mol Cancer Res       Date:  2016-06-13       Impact factor: 5.852

3.  Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior.

Authors:  Akimasa Hayashi; Naoko Yamauchi; Junji Shibahara; Hiroshi Kimura; Teppei Morikawa; Shumpei Ishikawa; Genta Nagae; Akihiro Nishi; Yoshihiro Sakamoto; Norihiro Kokudo; Hiroyuki Aburatani; Masashi Fukayama
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

4.  Generation of metastatic melanoma specific antibodies by affinity purification.

Authors:  Birgit Schütz; Anita Koppensteiner; David Schörghofer; Katharina Kinslechner; Gerald Timelthaler; Robert Eferl; Markus Hengstschläger; Albert Missbichler; Harald Hundsberger; Mario Mikula
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells.

Authors:  T Redmer; I Walz; B Klinger; S Khouja; Y Welte; R Schäfer; C Regenbrecht
Journal:  Oncogenesis       Date:  2017-01-23       Impact factor: 7.485

6.  Melanoma cells replicate through chemotherapy by reducing levels of key homologous recombination protein RAD51 and increasing expression of translesion synthesis DNA polymerase ζ.

Authors:  Liang Song; Ewan M McNeil; Ann-Marie Ritchie; Katy R Astell; Charlie Gourley; David W Melton
Journal:  BMC Cancer       Date:  2017-12-18       Impact factor: 4.430

Review 7.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.

Authors:  Brock J Sishc; Anthony J Davis
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

8.  A375 melanoma cells are sensitized to cisplatin-induced toxicity by a synthetic nitro-flavone derivative 2-(4-Nitrophenyl)-4H-chromen-4-one through inhibition of PARP1.

Authors:  Anindita Mitra; Rita Ghosh
Journal:  Mol Biol Rep       Date:  2021-08-03       Impact factor: 2.316

9.  Bioinformatics analysis of proteomics profiles in senescent human primary proximal tubule epithelial cells.

Authors:  Yang Lu; Jingchao Wang; Chen Dapeng; Di Wu; Guangyan Cai; Xiangmei Chen
Journal:  BMC Nephrol       Date:  2016-04-01       Impact factor: 2.388

10.  XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.

Authors:  Stephanie B Hatch; Lonnie P Swift; Simona Caporali; Rebecca Carter; Esme J Hill; Thomas P MacGregor; Stefania D'Atri; Mark R Middleton; Peter J McHugh; Ricky A Sharma
Journal:  Int J Cancer       Date:  2013-11-14       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.